AMSBIO Lipidure®-Coat low adhesion plates and dishes are shown in cited research to be one of the most effective tools for state-of-the-art 3D spheroid cell culture. These new plates and dishes are available in 384-well format optimised for drug screening or other high throughput applications. Spheroid cell culture is based on the spontaneous formation of […]
Austin, TX — Bioo Scientific is offering a new set of ELISA tests for the detection of Epizootic Hemorrhagic Disease Virus (EHDV), an orbivirus that infects most wild and domestic ruminants. EHD is endemic in many countries, particularly affecting white-tailed deer in North America. Two kits are currently available; the NovareDx™ – EHDV Detection Kit […]
Austin, TX– NanoHybrids Corporation, a provider of nanotechnology-based contrast agents announced the launch of its new website and premium product line of gold nanoparticles specially designed to improve imaging results. The company’s initial technology platform was developed in collaboration with researchers from the Biomedical Engineering Department at The University of Texas at Austin and M.D. […]
SAN FRANCISCO, Calif.,– Bell Biosystems Inc. announced two major developments in its pioneering efforts to create synthetic organelles for life science research: Series A financing and acceptance into the Janssen Labs Program at QB3@953 in San Francisco, the premier life science startup incubator in the Bay Area. The new funds are being used to scale […]
BellBrook Labs Partners with Lucerna-Chem for Distribution of Transcreener HTS Assays in Switzerland
Madison, WI – BellBrook Labs has partnered with Lucerna-Chem for distribution of their Transcreener® HTS Assay products in Switzerland as of January 2014. The partnership leverages Lucerna-Chem’s existing supply arrangements with pharma and biotech companies in Basel and key academic centers focused on drug discovery. Lucerna-Chem will distribute BellBrook’s full product line of Transcreener HTS […]
ALAMEDA, Calif.– BioTime, Inc. (NYSE MKT: BTX) today announced it has sold 70,000 shares of a newly authorized Series A Convertible Preferred Stock for $3.5 million. The Series A Preferred Stock carries a cumulative annual 3% preferred dividend or $1.50 per share, in preference to BioTime common shares. Each share of Series A Preferred Stock […]
Menlo Park, CA –DNA2.0 today announced the release of a set of CRISPR/Cas9 tools for genome editing and engineering. At the heart of DNA2.0’s CRISPR toolset is the revolutionary NickaseNinja system, which offers the high fidelity editing of Cas9 nickase plus guide RNA (gRNA) pairs, in a convenient single-vector format. By co-expressing two guide RNAs […]
Rockville, MD –The acquisition of BioCheck expands OriGene’s IVD portfolio and capabilities for future product development, leveraging its current leading Chinese diagnostics channels. China’s IVD market is among the fastest growing in the world, and from recent annual growth rates, it is predicted to be the world’s second largest IVD market by 2017. The market […]
Littleton, Colo. –– Novus Biologicals, a leading developer and marketer of life sciences research products, is pleased to announce a second distribution partner in China, MultiSciences (LIANKE) Biotech Co., Ltd. R&D expenditures in China increased from $2 billion in 2007 to $8.4 billion in 2012, a compound annual growth rate of 32.8%.1 “As the most […]
Biognosys AG, a Swiss Proteomics Company, announced today the launch of its PlasmaDeepDive™ MRM Panel that enables quantification of 100 human plasma proteins in a single LC-MRM measurement. PlasmaDeepDive™ is specifically designed for monitoring protein levels in depleted plasma or serum and sets a new standard for clinical research, biomarker screening and development of companion […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
